PTCH1 and cancer: In the absence of Hh ligands, PTCH1 exhibits a constitutive activity that represses the G protein-coupled receptor Smoothened (SMO) and prevents activation of the Glioma-associated oncogene (GLI) family of transcription factors, which have been implicated in tumourigenesis and cancer progression in many malignancies [1,2].